Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Icahn Enterprises L P - Unit | Mr. Carl C. Icahn | Director, Ten Percent Owner, CHAIRMAN OF THE BOARD | Other type of transaction at price $ 7.01 per share. | 23 Sep 2026 | 40,531,194 | 658,924,537 | - | 7.0 | 284,196,626 | - |
| ONE Nuclear Energy Inc | Mr. Daniel J. Hennessy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 5,203,333 | 5,703,333 | - | - | - | |
| ONE Nuclear Energy Inc | Mr. Thomas D. Hennessy | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 5,203,333 | 5,703,333 | - | - | - | |
| LoanDepot Inc (Class A) | Mr. Jeff DerGurahian | Chief Investment Officer | 23 Sep 2026 | 1,598,390 | 2,916,074 (4%) | 2% | 0 | - | ||
| LoanDepot Inc (Class A) | Mr. Jeff DerGurahian | Chief Investment Officer | Other type of transaction at price $ 0.00 per share. | 23 Sep 2026 | 1,598,390 | 0 | - | 0 | - | |
| Theravance Biopharma Inc | Mr. Rick E. Winningham | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 1,382,272 | 228,750 (0%) | 2% | - | - | |
| Crescent Energy Co (Class A) | Mr. David C. Rockecharlie | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 23 Sep 2026 | 900,000 | 1,107,341 | - | 0 | - | |
| ONE Nuclear Energy Inc | Mr. Thomas D. Hennessy | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 750,000 | 750,000 | - | - | - | |
| Cerebras Systems Inc | Mr. Lior Susan | Director | Other type of transaction at price $ 0.00 per share. | 23 Sep 2026 | 451,118 | 6,490,711 | - | - | - | |
| Crescent Energy Co (Class A) | Mr. John Clayton Rynd | EVP, Investments | Other type of transaction at price $ 0.00 per share. | 23 Sep 2026 | 300,000 | 339,684 | - | 0 | - | |
| Crescent Energy Co (Class A) | Ms. Brandi Kendall | Director, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 23 Sep 2026 | 300,000 | 356,023 | - | 0 | - | |
| Fastly Inc (Class A) | Mr. Artur Bergman | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 30.15 per share. | 23 Sep 2026 | 262,185 | 1,223,875 (1%) | 0% | 30.2 | 7,904,878 | - |
| Wheeler Real Estate Investment Trust Inc | Mr. Joseph D. Stilwell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 257,902 | 442,563 (4%) | 2% | - | - | |
| ONE Nuclear Energy Inc | Mr. Nicholas Geeza | CFO of Predecessor Issuer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 250,000 | 250,000 | - | - | - | |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 355.50 per share. | 23 Sep 2026 | 230,031 | 36,097,830 (9%) | 0% | 355.5 | 81,776,021 | - |
| Theravance Biopharma Inc | Mr. Brett A. Grimaud | SVP, GEN COUNSEL AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 223,917 | 131,251 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Mr. Aziz Sawaf, C.F.A. | SVP & CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 204,966 | 131,875 (0%) | 0% | - | - | |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 354.71 per share. | 23 Sep 2026 | 186,809 | 36,327,861 (9%) | 0% | 354.7 | 66,263,020 | - |
| Wheeler Real Estate Investment Trust Inc | Mr. Joseph D. Stilwell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 184,655 | 184,661 (1%) | 1% | - | - | |
| Janus Intl Grp Inc (Class A) | Mr. Anselm Wong | CFO, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 176,056 | 601,693 | - | 0 | - | |
| Janus Intl Grp Inc (Class A) | Mr. Norman Nettie | EVP, Corporate Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 176,056 | 529,781 | - | 0 | - | |
| Janus Intl Grp Inc (Class A) | Mr. Morgan Hodges | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 176,056 | 252,377 | - | 0 | - | |
| Theravance Biopharma Inc | Mr. Rick E. Winningham | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 151,875 | 76,875 (0%) | 0% | - | - | |
| Bluerock Private Real Estate | Mr. R. Ramin Kamfar | Director | Other type of transaction at price $ 12.48 per share. | 23 Sep 2026 | 150,000 | 329,763 | - | 12.5 | 1,871,280 | - |
| Bluerock Private Real Estate | Mr. R. Ramin Kamfar | Director | Purchase of securities on an exchange or from another person at price $ 12.48 per share. | 23 Sep 2026 | 150,000 | 329,763 | - | 12.5 | 1,871,280 | - |
| Theravance Biopharma Inc | Ms. Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 124,414 | 89,062 (0%) | 0% | - | - | |
| Bluerock Private Real Estate | Mr. R. Ramin Kamfar | Director | Other type of transaction at price $ 12.39 per share. | 23 Sep 2026 | 115,229 | 450,800 | - | 12.4 | 1,427,676 | - |
| Bluerock Private Real Estate | Mr. R. Ramin Kamfar | Director | Purchase of securities on an exchange or from another person at price $ 12.39 per share. | 23 Sep 2026 | 115,229 | 450,800 | - | 12.4 | 1,427,676 | - |
| Theravance Biopharma Inc | Mr. Aziz Sawaf, C.F.A. | SVP & CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 108,436 | 23,439 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Mr. Brett A. Grimaud | SVP, GEN COUNSEL AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 107,812 | 23,439 (0%) | 0% | - | - | |
| Workday (Class A) | Mr. David A. Duffield | Ten Percent Owner | 23 Sep 2026 | 99,613 | 204,662 (0%) | 0% | 0 | - | ||
| Theravance Biopharma Inc | Dr. Aine Miller, PhD | SVP, DEV & HEAD OF IRE OFFICE | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 96,718 | 0 (0%) | 0% | - | - | |
| Best Buy | Ms. Kathleen Scarlett | SEVP, CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 70.50 per share. | 23 Sep 2026 | 96,166 | 232,235 (0%) | 0% | 70.5 | 6,779,703 | - |
| Theravance Biopharma Inc | Dr. Aine Miller, PhD | SVP, DEV & HEAD OF IRE OFFICE | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 93,108 | 96,718 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Mr. Rick E. Winningham | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 92,567 | 0 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Mr. Dean Jonathan Mitchell | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 91,204 | 6,009 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Ms. Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 89,062 | 0 (0%) | 0% | - | - | |
| Best Buy | Ms. Kathleen Scarlett | SEVP, CHRO | Sale of securities on an exchange or to another person at price $ 92.07 per share. | 23 Sep 2026 | 88,110 | 116,173 (0%) | 0% | 92.1 | 8,112,305 | - |
| Fastly Inc (Class A) | Mr. Artur Bergman | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 30.65 per share. | 23 Sep 2026 | 85,517 | 1,138,358 (1%) | 0% | 30.6 | 2,621,096 | - |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 356.58 per share. | 23 Sep 2026 | 85,221 | 36,012,609 (9%) | 0% | 356.6 | 30,388,104 | - |
| Theravance Biopharma Inc | Mr. Rick E. Winningham | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 76,875 | 0 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Dr. Laurie Smaldone Alsup, M.D. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 74,980 | 6,009 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Mr. Donal O'Connor | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 74,204 | 6,009 (0%) | 0% | - | - | |
| Broadcom | Dr. Henry Samueli,PhD | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Sep 2026 | 72,474 | 35,810,224 (8%) | 0% | 0 | - | |
| Workday (Class A) | Mr. David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 192.10 per share. | 23 Sep 2026 | 63,855 | 131,858 (0%) | 0% | 192.1 | 12,266,475 | - |
| Wheeler Real Estate Investment Trust Inc | Mr. Joseph D. Stilwell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 62,829 | 62,829 (0%) | 0% | - | - | |
| Spectral AI Inc (Class A) | Dr. J. Michael DiMaio, M.D. | Director | Grant, award, or other acquisition of securities at price $ 1.67 per share. | 23 Sep 2026 | 60,000 | 2,890,847 | - | 1.7 | 100,200 | - |
| Theravance Biopharma Inc | Dr. Deepika Rachel Pakianathan, PhD | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 58,065 | 6,009 (0%) | 0% | - | - | |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 357.52 per share. | 23 Sep 2026 | 50,998 | 35,961,611 (9%) | 0% | 357.5 | 18,232,805 | - |
| Clorox | Ms. Linda J. Rendle | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 83.94 per share. | 23 Sep 2026 | 50,988 | 252,149 (0%) | 0% | 83.9 | 4,279,933 | - |
| Marcus Corp | Ms. Diane Marcus Gershowitz | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.61 per share. | 23 Sep 2026 | 50,000 | 125,617 (0%) | 0% | 27.6 | 1,380,500 | - |
| Snowflake Inc (Class A) | Dr. Benoit Dageville, PhD | Director | Sale of securities on an exchange or to another person at price $ 339.08 per share. | 23 Sep 2026 | 50,000 | 2,434,879 | - | 339.1 | 16,954,000 | - |
| Leap Therapeutics Inc | Ms. Patricia Martin | Director | Sale of securities on an exchange or to another person at price $ 3.86 per share. | 23 Sep 2026 | 50,000 | 118,750 (0%) | 0% | 3.9 | 193,000 | - |
| Anixa Biosciences Inc | Mr. Lewis H. Titterton, Jr | Director | Purchase of securities on an exchange or from another person at price $ 2.69 per share. | 23 Sep 2026 | 49,036 | 1,046,003 (5%) | 0% | 2.7 | 131,907 | - |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 358.42 per share. | 23 Sep 2026 | 44,618 | 35,916,993 (8%) | 0% | 358.4 | 15,991,984 | - |
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | 23 Sep 2026 | 43,224 | 531,257 (0%) | 0% | 0 | - | ||
| Precigen Inc | Mr. Harry Thomasian, Jr | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.33 per share. | 23 Sep 2026 | 42,918 | 311,911 (0%) | 0% | 2.3 | 99,999 | - |
| Theravance Biopharma Inc | Ms. Susannah Gray, M.B.A. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 42,137 | 6,009 (0%) | 0% | - | - | |
| ONE Nuclear Energy Inc | Mr. Daniel J. Hennessy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 41,666 | 5,744,999 | - | - | - | |
| ONE Nuclear Energy Inc | Mr. Thomas D. Hennessy | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 41,666 | 5,744,999 | - | - | - | |
| Bowman Consulting Grp Ltd | Mr. Gary Bowman | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 42.55 per share. | 23 Sep 2026 | 37,500 | 780,948 | - | 42.6 | 1,595,738 | - |
| Viavi Soln Inc | Mr. Luke M. Scrivanich | SVP General Manager OSP | Sale of securities on an exchange or to another person at price $ 36.24 per share. | 23 Sep 2026 | 35,866 | 39,598 (0%) | 0% | 36.2 | 1,299,784 | - |
| Wheeler Real Estate Investment Trust Inc | Mr. Joseph D. Stilwell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 35,768 | 61,284 (0%) | 0% | - | - | |
| Soluna Holdings Inc | Ms. Jessica L. Thomas | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.26 per share. | 23 Sep 2026 | 30,000 | 1,481,417 | - | 1.3 | 37,800 | - |
| ONE Nuclear Energy Inc | Ms. Poonam Sharma Mathis | Director of Predecessor Issuer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 30,000 | 30,000 | - | - | - | |
| Bluerock Private Real Estate | Mr. R. Ramin Kamfar | Director | Other type of transaction at price $ 12.46 per share. | 23 Sep 2026 | 29,970 | 480,770 | - | 12.5 | 373,348 | - |
| Bluerock Private Real Estate | Mr. R. Ramin Kamfar | Director | Purchase of securities on an exchange or from another person at price $ 12.46 per share. | 23 Sep 2026 | 29,970 | 480,770 | - | 12.5 | 373,348 | - |
| Best Buy | Ms. Kathleen Scarlett | SEVP, CHRO | Sale of securities on an exchange or to another person at price $ 92.41 per share. | 23 Sep 2026 | 27,952 | 204,283 (0%) | 0% | 92.4 | 2,583,058 | - |
| Medpace Holdings Inc | Mr. August J. Troendle, M.D. | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 621.33 per share. | 23 Sep 2026 | 27,833 | 389,456 (1%) | 0% | 621.3 | 17,293,478 | - |
| Cerebras Systems Inc | Mr. Lior Susan | Director | Other type of transaction at price $ 0.00 per share. | 23 Sep 2026 | 25,757 | 351,927 | - | - | - | |
| Wheeler Real Estate Investment Trust Inc | Mr. Joseph D. Stilwell | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 25,516 | 25,516 (0%) | 0% | - | - | |
| Howard Hughes Holdings Inc | Mr. Marc Grandisson | Director, Executive Chairman, Vantage | Purchase of securities on an exchange or from another person at price $ 64.12 per share. | 23 Sep 2026 | 25,000 | 96,943 (0%) | 0% | 64.1 | 1,602,938 | - |
| ONE Nuclear Energy Inc | Mr. Brian Bonner | Director of Predecessor Issuer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 25,000 | 25,000 | - | - | - | |
| ONE Nuclear Energy Inc | Mr. Grant R. Allen | Director of Predecessor Issuer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 25,000 | 25,000 | - | - | - | |
| ONE Nuclear Energy Inc | Ms. Anna Brunelle | Director of Predecessor Issuer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 25,000 | 25,000 | - | - | - | |
| ONE Nuclear Energy Inc | Mr. Javier Saade | Director of Predecessor Issuer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 25,000 | 25,000 | - | - | - | |
| Workday (Class A) | Mr. David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 192.84 per share. | 23 Sep 2026 | 24,934 | 106,924 (0%) | 0% | 192.8 | 4,808,283 | - |
| Fastly Inc (Class A) | Mr. Artur Bergman | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 29.17 per share. | 23 Sep 2026 | 24,300 | 1,486,060 (2%) | 0% | 29.2 | 708,831 | - |
| Cerebras Systems Inc | Mr. Lior Susan | Director | Other type of transaction at price $ 0.00 per share. | 23 Sep 2026 | 23,735 | 309,603 | - | - | - | |
| Theravance Biopharma Inc | Mr. Aziz Sawaf, C.F.A. | SVP & CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 23,439 | 0 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Mr. Brett A. Grimaud | SVP, GEN COUNSEL AND SECRETARY | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 23,439 | 0 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Mr. Rick E. Winningham | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 23,400 | 0 (0%) | 0% | - | - | |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 355.55 per share. | 23 Sep 2026 | 22,946 | 29,938,470 (7%) | 0% | 355.5 | 8,158,450 | - |
| Abacus Life Inc (Class A) | Mr. Matthew Ganovsky | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.74 per share. | 23 Sep 2026 | 22,800 | 8,651,148 | - | 7.7 | 176,472 | - |
| Abacus Life Inc (Class A) | Mr. Kevin Scott Kirby | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.74 per share. | 23 Sep 2026 | 22,745 | 12,506,060 | - | 7.7 | 176,046 | - |
| Abacus Life Inc (Class A) | Mr. Tod Sean McNealy | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.74 per share. | 23 Sep 2026 | 22,700 | 12,506,952 | - | 7.7 | 175,698 | - |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 354.75 per share. | 23 Sep 2026 | 22,624 | 29,961,416 (7%) | 0% | 354.8 | 8,025,864 | - |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 359.44 per share. | 23 Sep 2026 | 22,579 | 35,894,414 (8%) | 0% | 359.4 | 8,115,796 | - |
| Capitol Federal Fin | Mr. William Joseph Skrobacz, Jr | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 22,500 | 58,989 (0%) | 0% | - | - | |
| Bowman Consulting Grp Ltd | Mr. Gary Bowman | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 42.55 per share. | 23 Sep 2026 | 22,500 | 1,272,838 | - | 42.6 | 957,443 | - |
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 251.45 per share. | 23 Sep 2026 | 22,007 | 507,233 (0%) | 0% | 251.4 | 5,533,568 | - |
| Celestica Inc | Mr. Todd C. Cooper | President | Sale of securities on an exchange or to another person at price $ 360.00 per share. | 23 Sep 2026 | 20,118 | 73,252 (0%) | 0% | 360 | 7,242,480 | - |
| Accuray Inc | Mr. Ali Pervaiz | SVP Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 19,811 | 375,174 (0%) | 0% | 0 | - | |
| Snowflake Inc (Class A) | Dr. Benoit Dageville, PhD | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Sep 2026 | 16,668 | 2,484,879 | - | 0 | - | |
| Medpace Holdings Inc | Mr. August J. Troendle, M.D. | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 628.64 per share. | 23 Sep 2026 | 16,083 | 417,289 (1%) | 0% | 628.6 | 10,110,417 | - |
| Old Second Bancorp Inc | Mr. Gary S. Collins | Director, VICE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 24.69 per share. | 23 Sep 2026 | 16,000 | 14,136 (0%) | 0% | 24.7 | 395,080 | - |
| Culp Inc | Mr. Fred A. Jackson | Former Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 14,389 | 105,462 (0%) | 0% | 0 | - | |
| Pinterest Inc (Class A) | Ms. Wanjiku Juanita Walcott | Chief Legal & Bus Affairs Ofc. | Sale of securities on an exchange or to another person at price $ 18.21 per share. | 23 Sep 2026 | 14,103 | 658,902 (0%) | 0% | 18.2 | 256,773 | - |
| Clipper Realty Inc | Mr. Shmuel Levinson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.38 per share. | 23 Sep 2026 | 13,606 | 401,704 (2%) | 0% | 3.4 | 45,947 | - |
| Clorox | Mr. Chris T. Hyder | EVP-Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 83.94 per share. | 23 Sep 2026 | 13,342 | 90,202 (0%) | 0% | 83.9 | 1,119,927 | - |
| Culp Inc | Ms. Kimberly B. Gatling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 13,190 | 62,592 (0%) | 0% | 0 | - | |
| Culp Inc | Mr. William L. Tyson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 13,190 | 13,990 (0%) | 0% | 0 | - | |
| Culp Inc | Ms. Lynn D. Heatherton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 13,190 | 13,190 (0%) | 0% | 0 | - | |
| Aktis Oncology Inc | Dr. Akos Czibere, M.D.,PhD | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.95 per share. | 23 Sep 2026 | 12,500 | 12,500 | - | 5.0 | 61,875 | - |
| Clorox | Ms. Kirsten M. Marriner | EVP - Chief Admin Officer | Grant, award, or other acquisition of securities at price $ 83.94 per share. | 23 Sep 2026 | 12,389 | 76,683 (0%) | 0% | 83.9 | 1,039,933 | - |
| Clorox | Mr. Luc Bellet | EVP - Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 83.94 per share. | 23 Sep 2026 | 11,913 | 74,669 (0%) | 0% | 83.9 | 999,977 | - |
| Clorox | Ms. Angela C. Hilt | EVP - Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 83.94 per share. | 23 Sep 2026 | 11,436 | 67,547 (0%) | 0% | 83.9 | 959,938 | - |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 361.79 per share. | 23 Sep 2026 | 11,309 | 35,882,698 (8%) | 0% | 361.8 | 4,091,483 | - |
| Skillsoft Corp (Class A) | Mr. Ronald W. Hovsepian | Director, CEO & Executive Chair | Purchase of securities on an exchange or from another person at price $ 5.93 per share. | 23 Sep 2026 | 11,196 | 382,267 | - | 5.9 | 66,415 | - |
| NextNav Inc | Mr. Timothy A. Gray | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.64 per share. | 23 Sep 2026 | 11,099 | 120,687 | - | 14.6 | 162,538 | - |
| Precigen Inc | Mr. Harry Thomasian, Jr | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.72 per share. | 23 Sep 2026 | 10,744 | 268,993 (0%) | 0% | 4.7 | 50,712 | - |
| Clorox | Ms. Nina Barton | EVP-Chief Growth & Strategy Of | Grant, award, or other acquisition of securities at price $ 83.94 per share. | 23 Sep 2026 | 10,721 | 37,164 (0%) | 0% | 83.9 | 899,921 | - |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 356.59 per share. | 23 Sep 2026 | 10,058 | 29,928,412 (7%) | 0% | 356.6 | 3,586,582 | - |
| General American Investors Co. Inc | Mr. Spencer Davidson | Chairman | Purchase of securities on an exchange or from another person at price $ 22.75 per share. | 23 Sep 2026 | 10,000 | 189,387 | - | 22.8 | 227,500 | - |
| AvePoint Inc (Class A) | Mr. Brian Michael Brown | Director, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 13.07 per share. | 23 Sep 2026 | 10,000 | 374,604 | - | 13.1 | 130,700 | - |
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 252.36 per share. | 23 Sep 2026 | 9,633 | 497,600 (0%) | 0% | 252.4 | 2,430,952 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 23 Sep 2026 | 9,500 | 333,943 (0%) | 0% | 117.8 | 1,118,720 | - |
| Clipper Realty Inc | Mr. Shmuel Levinson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.38 per share. | 23 Sep 2026 | 9,317 | 411,021 (2%) | 0% | 3.4 | 31,487 | - |
| Accuray Inc | Mr. Ali Pervaiz | SVP Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.23 per share. | 23 Sep 2026 | 8,915 | 366,259 (0%) | 0% | 0.2 | 2,010 | - |
| Credo Tech Grp Holding Ltd | Mr. Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 193.93 per share. | 23 Sep 2026 | 7,736 | 5,695,961 | - | 193.9 | 1,500,243 | - |
| Fastly Inc (Class A) | Mr. Artur Bergman | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 28.04 per share. | 23 Sep 2026 | 7,600 | 1,510,360 (2%) | 0% | 28.0 | 213,104 | - |
| BP PLC (ADR) | Ms. Katherine Anne Thomson | Executive Director,Chief Financial Officer | 23 Sep 2026 | 7,447 | 1,428,286 (0%) | 0% | 5.5 | 40,925 | - | |
| Aktis Oncology Inc | Dr. Akos Czibere, M.D.,PhD | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.03 per share. | 23 Sep 2026 | 7,401 | 0 | - | 21.0 | 155,648 | - |
| ONEOK | Mr. Walter S. Hulse, III | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 7,238 | 176,223 (0%) | 0% | - | - | |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 357.66 per share. | 23 Sep 2026 | 6,959 | 29,921,453 (7%) | 0% | 357.7 | 2,488,956 | - |
| Celestica Inc | Mr. Robert A. Mionis | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 365.69 per share. | 23 Sep 2026 | 6,749 | 3,960 (0%) | 0% | 365.7 | 2,468,042 | - |
| ONEOK | Mr. Lyndon C. Taylor | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 6,369 | 12,182 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Mr. Dean Jonathan Mitchell | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 6,009 | 0 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Dr. Deepika Rachel Pakianathan, PhD | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 6,009 | 0 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Mr. Donal O'Connor | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 6,009 | 0 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Dr. Laurie Smaldone Alsup, M.D. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 6,009 | 0 (0%) | 0% | - | - | |
| Theravance Biopharma Inc | Ms. Susannah Gray, M.B.A. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Sep 2026 | 6,009 | 0 (0%) | 0% | - | - | |
| Bluerock Private Real Estate | Mr. R. Ramin Kamfar | Director | Other type of transaction at price $ 12.75 per share. | 23 Sep 2026 | 5,808 | 335,571 | - | 12.8 | 74,052 | - |
| Bluerock Private Real Estate | Mr. R. Ramin Kamfar | Director | Purchase of securities on an exchange or from another person at price $ 12.45 per share. | 23 Sep 2026 | 5,808 | 335,571 | - | 12.5 | 72,310 | - |
| Credo Tech Grp Holding Ltd | Mr. Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 195.03 per share. | 23 Sep 2026 | 5,364 | 5,690,597 | - | 195.0 | 1,046,160 | - |
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 253.32 per share. | 23 Sep 2026 | 5,347 | 492,253 (0%) | 0% | 253.3 | 1,354,514 | - |
| Aktis Oncology Inc | Dr. Akos Czibere, M.D.,PhD | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.19 per share. | 23 Sep 2026 | 5,099 | 7,401 | - | 20.2 | 102,973 | - |
| Inhibrx Biosciences Inc | Jon Faiz Kayyem | Director | Purchase of securities on an exchange or from another person at price $ 100.00 per share. | 23 Sep 2026 | 5,000 | 434,360 | - | 100 | 500,000 | Common Stock |
| General American Investors Co. Inc | Mr. Eugene S. Stark | VP Administration | Purchase of securities on an exchange or from another person at price $ 22.75 per share. | 23 Sep 2026 | 5,000 | 39,000 | - | 22.8 | 113,750 | - |
| First Trust High Yield Opportunities 2027 Term Fund | Mr. William A. Housey, Jr | Officer of Advisor, Port. Mgr. | Purchase of securities on an exchange or from another person at price $ 12.95 per share. | 23 Sep 2026 | 5,000 | 16,841 | - | 13.0 | 64,750 | - |
| Inhibrx Inc | Dr. Jon Faiz Kayyem, PhD | Director | Purchase of securities on an exchange or from another person at price $ 100.00 per share. | 23 Sep 2026 | 5,000 | 434,360 | - | 100 | 500,000 | - |
| Workday (Class A) | Mr. David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 190.95 per share. | 23 Sep 2026 | 4,849 | 195,713 (0%) | 0% | 190.9 | 925,914 | - |
| Credo Tech Grp Holding Ltd | Mr. Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 192.98 per share. | 23 Sep 2026 | 4,700 | 5,703,697 | - | 193.0 | 907,008 | - |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 358.47 per share. | 23 Sep 2026 | 4,560 | 29,916,893 (7%) | 0% | 358.5 | 1,634,623 | - |
| Atricure Inc | Mr. Salvatore Privitera, J.D. | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 23 Sep 2026 | 4,519 | 142,745 (0%) | 0% | 60 | 271,140 | - |
| ONEOK | Mr. Sheridan C. Swords | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 4,343 | 240,716 (0%) | 0% | - | - | |
| Owens & Minor Inc | Mr. Jonathan A. Leon | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.85 per share. | 23 Sep 2026 | 4,265 | 286,268 (0%) | 0% | 0.8 | 3,625 | - |
| Credo Tech Grp Holding Ltd | Mr. Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 191.87 per share. | 23 Sep 2026 | 4,000 | 5,708,397 | - | 191.9 | 767,464 | - |
| Progyny Inc | Ms. Allison Swartz | EVP, GC | Sale of securities on an exchange or to another person at price $ 26.10 per share. | 23 Sep 2026 | 3,903 | 75,816 (0%) | 0% | 26.1 | 101,868 | - |
| CIENA Corp | Mr. T. Michael Nevens | Director | Sale of securities on an exchange or to another person at price $ 359.04 per share. | 23 Sep 2026 | 3,738 | 6,289 (0%) | 0% | 359.0 | 1,342,092 | - |
| Korn Ferry | Mr. Robert P. Rozek | EVP, CFO & CCO | Sale of securities on an exchange or to another person at price $ 75.03 per share. | 23 Sep 2026 | 3,709 | 155,254 (0%) | 0% | 75.0 | 278,283 | - |
| Celestica Inc | Mr. Robert A. Mionis | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 366.44 per share. | 23 Sep 2026 | 3,672 | 288 (0%) | 0% | 366.4 | 1,345,568 | - |
| Lineage Inc | Mr. Paul Beiboer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 3,672 | 3,672 | - | 0 | - | |
| Scholastic Corp | Ms. Iole Lucchese | Director, EVP & CHIEF STRATEGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.09 per share. | 23 Sep 2026 | 3,565 | 51,597 (0%) | 0% | 35.1 | 125,096 | - |
| Celestica Inc | Mr. Robert A. Mionis | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 364.67 per share. | 23 Sep 2026 | 3,403 | 10,709 (0%) | 0% | 364.7 | 1,240,972 | - |
| John Wiley & Sons Inc (Class A) | Mr. William J. Pesce | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.75 per share. | 23 Sep 2026 | 3,275 | 91,384 (0%) | 0% | 47.7 | 156,381 | - |
| ONEOK | Mr. Walter S. Hulse, III | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.09 per share. | 23 Sep 2026 | 3,174 | 173,049 (0%) | 0% | 90.1 | 285,946 | - |
| Flowserve Corp | Mr. Matthew Carl Klopfer | President, FPD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 3,049 | 9,894 (0%) | 0% | 0 | - | |
| Credo Tech Grp Holding Ltd | Mr. Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 190.98 per share. | 23 Sep 2026 | 2,900 | 5,712,397 | - | 191.0 | 553,844 | - |
| ONEOK | Mr. Kevin L. Burdick | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 2,895 | 173,299 (0%) | 0% | - | - | |
| Immunovant Inc | Mr. Christopher A. Van Tuyl | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 36.36 per share. | 23 Sep 2026 | 2,846 | 176,545 (0%) | 0% | 36.4 | 103,481 | - |
| Natera Inc | Mr. Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 387.74 per share. | 23 Sep 2026 | 2,846 | 12,496 (0%) | 0% | 387.7 | 1,103,494 | - |
| PureCycle Tech Inc | Mr. Brad S. Kalter | General Counsel, CCO & Scty. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.15 per share. | 23 Sep 2026 | 2,830 | 130,497 | - | 5.2 | 14,575 | - |
| Nexstar Media Grp Inc | Mr. Andrew Alford | President, Broadcasting | Sale of securities on an exchange or to another person at price $ 165.69 per share. | 23 Sep 2026 | 2,823 | 11,726 (0%) | 0% | 165.7 | 467,743 | - |
| CIENA Corp | Mr. T. Michael Nevens | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Sep 2026 | 2,797 | 3,492 (0%) | 0% | - | - | |
| ONEOK | Mr. Lyndon C. Taylor | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.09 per share. | 23 Sep 2026 | 2,793 | 9,389 (0%) | 0% | 90.1 | 251,621 | - |
| Scholastic Corp | Ms. Sasha Quinton | EVP, Pres. CBG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.09 per share. | 23 Sep 2026 | 2,786 | 51,042 (0%) | 0% | 35.1 | 97,761 | - |
| Natera Inc | Mr. Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 387.65 per share. | 23 Sep 2026 | 2,734 | 12,723 (0%) | 0% | 387.7 | 1,059,847 | - |
| Scholastic Corp | Mr. Haji L. Glover | EVP & CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.09 per share. | 23 Sep 2026 | 2,626 | 22,696 (0%) | 0% | 35.1 | 92,146 | - |
| Celestica Inc | Mr. Robert A. Mionis | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 363.46 per share. | 23 Sep 2026 | 2,590 | 14,112 (0%) | 0% | 363.5 | 941,361 | - |
| Lumen Tech Inc | Mr. Donald Leroy Holt | Chief Acctg. Off. & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.13 per share. | 23 Sep 2026 | 2,538 | 164,019 (0%) | 0% | 6.1 | 15,558 | - |
| Celestica Inc | Mr. Robert A. Mionis | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 362.48 per share. | 23 Sep 2026 | 2,480 | 16,702 (0%) | 0% | 362.5 | 898,950 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 488.70 per share. | 23 Sep 2026 | 2,388 | 331,555 (0%) | 0% | 488.7 | 1,167,007 | - |
| Workday (Class A) | Mr. David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 188.92 per share. | 23 Sep 2026 | 2,324 | 202,338 (0%) | 0% | 188.9 | 439,039 | - |
| Natera Inc | Mr. Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 389.68 per share. | 23 Sep 2026 | 2,320 | 9,110 (0%) | 0% | 389.7 | 904,069 | - |
| ONEOK | Ms. Mary M. Spears | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 2,316 | 29,668 (0%) | 0% | - | - | |
| Natera Inc | Mr. Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 386.64 per share. | 23 Sep 2026 | 2,300 | 15,342 (0%) | 0% | 386.6 | 889,271 | - |
| Celestica Inc | Mr. Robert A. Mionis | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 361.22 per share. | 23 Sep 2026 | 2,294 | 19,182 (0%) | 0% | 361.2 | 828,639 | - |
| Barnes & Noble Education Inc | Mr. Gary Luster | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 23 Sep 2026 | 2,267 | 29,667 (0%) | 0% | 11.2 | 25,390 | - |
| Capital Bancorp Inc | Mr. Randall J. Levitt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.41 per share. | 23 Sep 2026 | 2,250 | 269,758 (1%) | 0% | 26.4 | 59,423 | - |
| Clorox | Ms. Laurene E. Peck | VP - CAO & Corp Controller | Grant, award, or other acquisition of securities at price $ 83.94 per share. | 23 Sep 2026 | 2,192 | 9,160 (0%) | 0% | 83.9 | 183,996 | - |
| Natera Inc | Mr. Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 386.71 per share. | 23 Sep 2026 | 2,175 | 15,457 (0%) | 0% | 386.7 | 841,104 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 489.52 per share. | 23 Sep 2026 | 2,162 | 329,393 (0%) | 0% | 489.5 | 1,058,351 | - |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 359.48 per share. | 23 Sep 2026 | 2,162 | 29,914,731 (7%) | 0% | 359.5 | 777,196 | - |
| Scholastic Corp | Mr. Jeffrey Mathews | EVP, CHIEF GROWTH OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.09 per share. | 23 Sep 2026 | 2,110 | 63,574 (0%) | 0% | 35.1 | 74,040 | - |
| Credo Tech Grp Holding Ltd | Mr. Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 190.03 per share. | 23 Sep 2026 | 2,100 | 5,715,297 | - | 190.0 | 399,064 | - |
| Alaska Air Grp Inc | Mr. Jason M Berry | EVP & Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 2,010 | 15,532 (0%) | 0% | - | - | |
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 254.35 per share. | 23 Sep 2026 | 2,000 | 490,253 (0%) | 0% | 254.3 | 508,699 | - |
| Nektar Therapeutics | Dr. Diana M. Brainard, M.D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 2,000 | 3,904 (0%) | 0% | 0 | - | |
| Nektar Therapeutics | Mr. Jeffrey R. Ajer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 2,000 | 4,277 (0%) | 0% | 0 | - | |
| Nektar Therapeutics | Mr. Roy A. Whitfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 2,000 | 16,417 (0%) | 0% | 0 | - | |
| Nektar Therapeutics | Mr. R. Scott Greer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 2,000 | 22,239 (0%) | 0% | 0 | - | |
| Nektar Therapeutics | Mr. Robert B. Chess | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 2,000 | 19,019 (0%) | 0% | 0 | - | |
| Rapport Therapeutics Inc | Mr. Abraham N. Ceesay, M.B.A. | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.05 per share. | 23 Sep 2026 | 1,952 | 457,025 | - | 39.1 | 76,230 | - |
| Natera Inc | Mr. Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 389.71 per share. | 23 Sep 2026 | 1,935 | 9,220 (0%) | 0% | 389.7 | 754,090 | - |
| Park Hotels & Resorts Inc | Ms. Patricia M. Bedient | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 1,923 | 159,885 (0%) | 0% | 0 | - | |
| Celestica Inc | Mr. Robert A. Mionis | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 360.36 per share. | 23 Sep 2026 | 1,920 | 21,476 (0%) | 0% | 360.4 | 691,891 | - |
| Charles Schwab | Mr. Stephen A. Ellis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.48 per share. | 23 Sep 2026 | 1,918 | 7,445 (0%) | 0% | 31.5 | 60,379 | - |
| ONEOK | Mr. Sheridan C. Swords | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.09 per share. | 23 Sep 2026 | 1,905 | 238,811 (0%) | 0% | 90.1 | 171,621 | - |
| BioCardia Inc | Dr. Peter Altman, PhD | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 23 Sep 2026 | 1,900 | 383,885 (5%) | 0% | 1.1 | 1,995 | - |
| Workday (Class A) | Mr. David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 193.62 per share. | 23 Sep 2026 | 1,875 | 105,049 (0%) | 0% | 193.6 | 363,039 | - |
| Five Below Inc | Mr. Kenneth R. Bull | COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 1,866 | 76,930 (0%) | 0% | 0 | - | |
| Dicks Sporting Goods Inc | Mr. Larry Fitzgerald, Jr | Director | Purchase of securities on an exchange or from another person at price $ 131.67 per share. | 23 Sep 2026 | 1,860 | 15,199 (0%) | 0% | 131.7 | 244,906 | - |
| Dell | Mr. Egon P. Durban | Director | Sale of securities on an exchange or to another person at price $ 548.40 per share. | 23 Sep 2026 | 1,850 | 1,405,236 (0%) | 0% | 548.4 | 1,014,540 | - |
| Impinj Inc | Mr. Chris Diorio, PhD | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 1,817 | 357,462 (1%) | 0% | 0 | - | |
| Lloyds Banking Grp PLC (ADR) | Ms. Catherine Woods | Non-Executive Director | 23 Sep 2026 | 1,810 | 129,156 (0%) | 0% | 1.1 | 1,983 | - | |
| Workday (Class A) | Mr. David A. Duffield | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 189.69 per share. | 23 Sep 2026 | 1,776 | 200,562 (0%) | 0% | 189.7 | 336,891 | - |
| Park Hotels & Resorts Inc | Mr. Thomas A. Natelli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 1,756 | 230,149 (0%) | 0% | 0 | - | |
| Park Hotels & Resorts Inc | Mr. Timothy J. Naughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 1,756 | 163,064 (0%) | 0% | 0 | - | |
| Kontoor Brands Inc | Mr. Michael J. Skipworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 1,611 | 1,611 (0%) | 0% | 0 | - | |
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 255.59 per share. | 23 Sep 2026 | 1,600 | 488,653 (0%) | 0% | 255.6 | 408,946 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 490.48 per share. | 23 Sep 2026 | 1,440 | 327,953 (0%) | 0% | 490.5 | 706,286 | - |
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 250.55 per share. | 23 Sep 2026 | 1,372 | 529,240 (0%) | 0% | 250.6 | 343,758 | - |
| Natera Inc | Mr. Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 388.76 per share. | 23 Sep 2026 | 1,341 | 11,155 (0%) | 0% | 388.8 | 521,332 | - |
| Natera Inc | Mr. Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 388.71 per share. | 23 Sep 2026 | 1,293 | 11,430 (0%) | 0% | 388.7 | 502,598 | - |
| Bakkt Holdings Inc (Class A) | Mr. Nicholas Baes | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.61 per share. | 23 Sep 2026 | 1,272 | 104,103 | - | 8.6 | 10,952 | - |
| Bakkt Holdings Inc (Class A) | Mr. Marc D’Annunzio | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 8.61 per share. | 23 Sep 2026 | 1,272 | 107,006 | - | 8.6 | 10,952 | - |
| ONEOK | Mr. Kevin L. Burdick | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.09 per share. | 23 Sep 2026 | 1,270 | 172,029 (0%) | 0% | 90.1 | 114,414 | - |
| Impinj Inc | Mr. Chris Diorio, PhD | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 1,224 | 355,645 (1%) | 0% | 0 | - | |
| Flowserve Corp | Mr. Matthew Carl Klopfer | President, FPD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.67 per share. | 23 Sep 2026 | 1,200 | 8,694 (0%) | 0% | 74.7 | 89,604 | - |
| Impinj Inc | Mr. Chris Diorio, PhD | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.20 per share. | 23 Sep 2026 | 1,197 | 356,265 (1%) | 0% | 177.2 | 212,108 | - |
| Allegiant Travel | Mr. Robert J. Neal | President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.26 per share. | 23 Sep 2026 | 1,173 | 34,816 (0%) | 0% | 77.3 | 90,626 | - |
| Scholastic Corp | Mr. Chris Lick | EVP, GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.09 per share. | 23 Sep 2026 | 1,119 | 11,455 (0%) | 0% | 35.1 | 39,266 | - |
| Allegiant Travel | Mr. Drew A. Wells | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.26 per share. | 23 Sep 2026 | 1,113 | 34,078 (0%) | 0% | 77.3 | 85,990 | - |
| Walt Disney | Mr. Brent A. Woodford | EVP, Control, Fin Plan & Tax | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 1,060 | 63,388 (0%) | 0% | - | - | |
| ONEOK | Ms. Mary M. Spears | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.09 per share. | 23 Sep 2026 | 1,016 | 28,652 (0%) | 0% | 90.1 | 91,531 | - |
| Howard Hughes Holdings Inc | Mr. Andrew D. Davis | Chief Operating Officer, HHC | Purchase of securities on an exchange or from another person at price $ 64.49 per share. | 23 Sep 2026 | 1,000 | 32,530 (0%) | 0% | 64.5 | 64,490 | - |
| RGC Resources Inc | Mr. John B. Williamson, III | Director | Purchase of securities on an exchange or from another person at price $ 21.19 per share. | 23 Sep 2026 | 1,000 | 180,931 (2%) | 0% | 21.2 | 21,190 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 491.66 per share. | 23 Sep 2026 | 824 | 327,129 (0%) | 0% | 491.7 | 405,124 | - |
| Alaska Air Grp Inc | Mr. Jason M Berry | EVP & Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.70 per share. | 23 Sep 2026 | 792 | 15,103 (0%) | 0% | 39.7 | 31,442 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 497.27 per share. | 23 Sep 2026 | 766 | 325,043 (0%) | 0% | 497.3 | 380,908 | - |
| Snowflake Inc (Class A) | Mr. Jonathan Mead Beaulier | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 336.36 per share. | 23 Sep 2026 | 755 | 211,619 | - | 336.4 | 253,953 | - |
| Scholastic Corp | Mr. Paul Hukkanen | SVP, CHIEF ACCT OFF | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.09 per share. | 23 Sep 2026 | 710 | 12,910 (0%) | 0% | 35.1 | 24,914 | - |
| Credo Tech Grp Holding Ltd | Mr. Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 195.68 per share. | 23 Sep 2026 | 700 | 5,689,897 | - | 195.7 | 136,977 | - |
| Five Below Inc | Mr. Eric M. Specter | CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 672 | 36,154 (0%) | 0% | 0 | - | |
| Capital Bancorp Inc | Mr. Marc H. Mcconnell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.09 per share. | 23 Sep 2026 | 646 | 19,172 (0%) | 0% | 16.1 | 10,394 | - |
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 249.21 per share. | 23 Sep 2026 | 645 | 530,612 (0%) | 0% | 249.2 | 160,739 | - |
| Datadog Inc (Class A) | Mr. Alexis Le-Quoc | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 256.15 per share. | 23 Sep 2026 | 620 | 488,033 (0%) | 0% | 256.1 | 158,811 | - |
| Impinj Inc | Mr. Cary Baker | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 596 | 81,463 (0%) | 0% | 0 | - | |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 496.38 per share. | 23 Sep 2026 | 525 | 325,809 (0%) | 0% | 496.4 | 260,598 | - |
| Five Below Inc | Mr. Amit Jhunjhunwala | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 522 | 20,783 (0%) | 0% | 0 | - | |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 361.48 per share. | 23 Sep 2026 | 512 | 29,913,822 (7%) | 0% | 361.5 | 185,078 | - |
| Semtech Corp | Mr. Paul V. Walsh,Jr | Director | Sale of securities on an exchange or to another person at price $ 172.61 per share. | 23 Sep 2026 | 500 | 26,600 (0%) | 0% | 172.6 | 86,305 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 492.54 per share. | 23 Sep 2026 | 480 | 326,649 (0%) | 0% | 492.5 | 236,421 | - |
| Impinj Inc | Mr. Cary Baker | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2026 | 479 | 80,867 (0%) | 0% | 0 | - | |
| Allient Inc | Mr. Michael R. Winter | Director | Purchase of securities on an exchange or from another person at price $ 108.97 per share. | 23 Sep 2026 | 457 | 1,304 (0%) | 0% | 109.0 | 49,799 | - |
| Allient Inc | Mr. Michael R. Winter | Director | Sale of securities on an exchange or to another person at price $ 109.27 per share. | 23 Sep 2026 | 457 | 39,154 (0%) | 0% | 109.3 | 49,936 | - |
| Unilever PLC (ADR) | Mr. Srinivas Phatak | Executive Director,Chief Financial Officer | 23 Sep 2026 | 451 | 58,156 (0%) | 0% | 47.1 | 21,261 | - | |
| Impinj Inc | Mr. Cary Baker | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.20 per share. | 23 Sep 2026 | 424 | 81,039 (0%) | 0% | 177.2 | 75,133 | - |
| Arrow Fin Corp | Mr. Gregory J. Champion | Director | Other type of transaction at price $ 36.97 per share. | 23 Sep 2026 | 423 | 12,505 (0%) | 0% | 37.0 | 15,638 | - |
| Prosperity Bancshares Inc | Mr. Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 68.61 per share. | 23 Sep 2026 | 411 | 83,693 (0%) | 0% | 68.6 | 28,198 | - |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 361.18 per share. | 23 Sep 2026 | 407 | 35,894,007 (8%) | 0% | 361.2 | 147,000 | - |
| Prosperity Bancshares Inc | Mr. Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 68.67 per share. | 23 Sep 2026 | 404 | 68,115 (0%) | 0% | 68.7 | 27,742 | - |
| Natera Inc | Mr. Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 385.10 per share. | 23 Sep 2026 | 400 | 17,632 (0%) | 0% | 385.1 | 154,041 | - |
| Broadcom | Dr. Henry Samueli,PhD | Director | Sale of securities on an exchange or to another person at price $ 360.76 per share. | 23 Sep 2026 | 397 | 29,914,334 (7%) | 0% | 360.8 | 143,222 | - |
| Walt Disney | Mr. Brent A. Woodford | EVP, Control, Fin Plan & Tax | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.66 per share. | 23 Sep 2026 | 393 | 62,995 (0%) | 0% | 103.7 | 40,738 | - |
| Natera Inc | Mr. Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 385.29 per share. | 23 Sep 2026 | 390 | 17,642 (0%) | 0% | 385.3 | 150,263 | - |
| Arrow Fin Corp | Mr. James M. Dawsey | Director | Other type of transaction at price $ 36.97 per share. | 23 Sep 2026 | 389 | 21,137 (0%) | 0% | 37.0 | 14,381 | - |
| Capital Bancorp Inc | Mr. Marc H. Mcconnell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.51 per share. | 23 Sep 2026 | 375 | 19,547 (0%) | 0% | 30.5 | 11,441 | - |
| Allient Inc | Mr. Michael R. Winter | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Sep 2026 | 374 | 39,611 (0%) | 0% | - | - | |
| Dycom Ind Inc | Ms. Carmen M. Sabater | Director | Purchase of securities on an exchange or from another person at price $ 280.62 per share. | 23 Sep 2026 | 350 | 7,154 (0%) | 0% | 280.6 | 98,217 | - |
| Allegiant Travel | Mr. Tyler Hollingsworth | SVP, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.26 per share. | 23 Sep 2026 | 330 | 19,766 (0%) | 0% | 77.3 | 25,496 | - |
| RGC Resources Inc | Mr. John B. Williamson, III | Director | Purchase of securities on an exchange or from another person at price $ 20.85 per share. | 23 Sep 2026 | 322 | 181,253 (2%) | 0% | 20.9 | 6,714 | - |
| Civista Bancshares Inc | Mr. Charles A. Parcher | President | Purchase of securities on an exchange or from another person at price $ 26.75 per share. | 23 Sep 2026 | 315 | 3,065 (0%) | 0% | 26.7 | 8,426 | - |
| Arrow Fin Corp | Ms. Tenee Rehm Casaccio | Director | Other type of transaction at price $ 36.97 per share. | 23 Sep 2026 | 304 | 29,169 (0%) | 0% | 37.0 | 11,239 | - |
| RGC Resources Inc | Mr. Paul W. Nester | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 21.08 per share. | 23 Sep 2026 | 300 | 134,512 (1%) | 0% | 21.1 | 6,324 | - |
| Arrow Fin Corp | Mr. Darrin Jahnel | Director | Other type of transaction at price $ 36.97 per share. | 23 Sep 2026 | 298 | 1,124 (0%) | 0% | 37.0 | 11,017 | - |
| Celestica Inc | Mr. Robert A. Mionis | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 367.34 per share. | 23 Sep 2026 | 288 | 0 (0%) | 0% | 367.3 | 105,794 | - |
| Bakkt Holdings Inc (Class A) | Mr. Joseph Sean-Walsh Henderson | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 8.61 per share. | 23 Sep 2026 | 282 | 12,672 | - | 8.6 | 2,428 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 498.38 per share. | 23 Sep 2026 | 270 | 324,773 (0%) | 0% | 498.4 | 134,563 | - |
| Allegiant Travel | Ms. Rebecca Aretos | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.26 per share. | 23 Sep 2026 | 264 | 10,404 (0%) | 0% | 77.3 | 20,397 | - |
| RGC Resources Inc | Mr. John B. Williamson, III | Director | Purchase of securities on an exchange or from another person at price $ 20.65 per share. | 23 Sep 2026 | 250 | 182,431 (2%) | 0% | 20.7 | 5,163 | - |
| RGC Resources Inc | Mr. John B. Williamson, III | Director | Purchase of securities on an exchange or from another person at price $ 20.75 per share. | 23 Sep 2026 | 250 | 182,003 (2%) | 0% | 20.8 | 5,188 | - |
| RGC Resources Inc | Mr. John B. Williamson, III | Director | Purchase of securities on an exchange or from another person at price $ 20.79 per share. | 23 Sep 2026 | 250 | 181,753 (2%) | 0% | 20.8 | 5,198 | - |
| RGC Resources Inc | Mr. John B. Williamson, III | Director | Purchase of securities on an exchange or from another person at price $ 20.83 per share. | 23 Sep 2026 | 250 | 181,503 (2%) | 0% | 20.8 | 5,208 | - |
| First Trust High Yield Opportunities 2027 Term Fund | Mr. William A. Housey, Jr | Officer of Advisor, Port. Mgr. | Purchase of securities on an exchange or from another person at price $ 12.92 per share. | 23 Sep 2026 | 241 | 11,841 | - | 12.9 | 3,114 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 500.05 per share. | 23 Sep 2026 | 240 | 324,443 (0%) | 0% | 500.1 | 120,012 | - |
| Kohl`s Corp | Ms. Wendy C. Arlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 237 | 64,171 (0%) | 0% | - | - | |
| Arrow Fin Corp | Mr. David G. Kruczlnicki | Director | Other type of transaction at price $ 36.97 per share. | 23 Sep 2026 | 228 | 60,847 (0%) | 0% | 37.0 | 8,429 | - |
| Arrow Fin Corp | Mr. Daniel James White | Director | Other type of transaction at price $ 36.97 per share. | 23 Sep 2026 | 228 | 8,478 (0%) | 0% | 37.0 | 8,429 | - |
| Five Below Inc | Mr. Graham Poliner | CSBIAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 224 | 15,758 (0%) | 0% | 0 | - | |
| Five Below Inc | Ms. Maureen Marie Gellerman | CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 224 | 9,028 (0%) | 0% | 0 | - | |
| Natera Inc | Mr. Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 390.53 per share. | 23 Sep 2026 | 220 | 9,000 (0%) | 0% | 390.5 | 85,916 | - |
| Rapport Therapeutics Inc | Mr. Abraham N. Ceesay, M.B.A. | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.86 per share. | 23 Sep 2026 | 215 | 456,810 | - | 39.9 | 8,570 | - |
| Arrow Fin Corp | Mr. Mark L. Behan | Director | Other type of transaction at price $ 36.97 per share. | 23 Sep 2026 | 211 | 11,112 (0%) | 0% | 37.0 | 7,801 | - |
| Arrow Fin Corp | Ms. Kristine D. Duffy, Ed.D. | Director | Other type of transaction at price $ 36.97 per share. | 23 Sep 2026 | 203 | 6,624 (0%) | 0% | 37.0 | 7,505 | - |
| Arrow Fin Corp | Mr. Philip C. Morris | Director | Other type of transaction at price $ 36.97 per share. | 23 Sep 2026 | 203 | 9,006 (0%) | 0% | 37.0 | 7,505 | - |
| Keysight Tech | Ms. Lisa Poole | VP and Controller | Sale of securities on an exchange or to another person at price $ 348.01 per share. | 23 Sep 2026 | 200 | 6,134 (0%) | 0% | 348.0 | 69,602 | - |
| Arrow Fin Corp | Dr. Colin L. Read, PhD | Director | Other type of transaction at price $ 36.97 per share. | 23 Sep 2026 | 194 | 33,777 (0%) | 0% | 37.0 | 7,172 | - |
| Kohl`s Corp | Ms. Wendy C. Arlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 186 | 63,934 (0%) | 0% | - | - | |
| Arrow Fin Corp | Mr. Rocco F. Arcuri, Sr | Director | Other type of transaction at price $ 36.97 per share. | 23 Sep 2026 | 186 | 16,066 (0%) | 0% | 37.0 | 6,876 | - |
| Kohl`s Corp | Ms. Robbin Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 185 | 52,948 (0%) | 0% | - | - | |
| RGC Resources Inc | Mr. John B. Williamson, III | Director | Purchase of securities on an exchange or from another person at price $ 20.70 per share. | 23 Sep 2026 | 178 | 182,181 (2%) | 0% | 20.7 | 3,685 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 493.72 per share. | 23 Sep 2026 | 160 | 326,489 (0%) | 0% | 493.7 | 78,996 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 495.17 per share. | 23 Sep 2026 | 155 | 326,334 (0%) | 0% | 495.2 | 76,752 | - |
| Timberland Bancorp Inc | Mr. Dean J. Brydon | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.82 per share. | 23 Sep 2026 | 148 | 35,773 (0%) | 0% | 44.8 | 6,633 | - |
| Kohl`s Corp | Mr. H. Charles Floyd | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 137 | 64,728 (0%) | 0% | - | - | |
| Timberland Bancorp Inc | Ms. Marci A. Basich | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.82 per share. | 23 Sep 2026 | 135 | 4,665 (0%) | 0% | 44.8 | 6,051 | - |
| Timberland Bancorp Inc | Mr. Dean J. Brydon | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.10 per share. | 23 Sep 2026 | 133 | 35,640 (0%) | 0% | 45.1 | 5,998 | - |
| Timberland Bancorp Inc | Mr. Jonathan Arthur Fischer | President/COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.82 per share. | 23 Sep 2026 | 128 | 6,422 (0%) | 0% | 44.8 | 5,737 | - |
| Timberland Bancorp Inc | Mr. Jonathan Arthur Fischer | President/COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.10 per share. | 23 Sep 2026 | 115 | 6,307 (0%) | 0% | 45.1 | 5,187 | - |
| Natera Inc | Mr. Jonathan Sheena | Director, CO-FOUNDER | Sale of securities on an exchange or to another person at price $ 390.42 per share. | 23 Sep 2026 | 110 | 9,000 (0%) | 0% | 390.4 | 42,946 | - |
| Kohl`s Corp | Mr. Jonas Prising | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 103 | 113,291 (0%) | 0% | - | - | |
| Kohl`s Corp | Mr. Yael Cosset | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 100 | 70,818 (0%) | 0% | - | - | |
| RGC Resources Inc | Mr. John B. Williamson, III | Director | Purchase of securities on an exchange or from another person at price $ 20.85 per share. | 23 Sep 2026 | 100 | 182,631 (2%) | 0% | 20.9 | 2,085 | - |
| RGC Resources Inc | Mr. John B. Williamson, III | Director | Purchase of securities on an exchange or from another person at price $ 20.80 per share. | 23 Sep 2026 | 100 | 182,531 (2%) | 0% | 20.8 | 2,080 | - |
| Timberland Bancorp Inc | Ms. Marci A. Basich | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.10 per share. | 23 Sep 2026 | 100 | 4,565 (0%) | 0% | 45.1 | 4,510 | - |
| Kohl`s Corp | Mr. Adolfo Villagomez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 99 | 44,066 (0%) | 0% | - | - | |
| Timberland Bancorp Inc | Ms. Breanne D. Antich | Chief Technology Officer/EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.82 per share. | 23 Sep 2026 | 97 | 3,793 (0%) | 0% | 44.8 | 4,348 | - |
| Prosperity Bancshares Inc | Mr. Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 67.76 per share. | 23 Sep 2026 | 96 | 68,519 (0%) | 0% | 67.8 | 6,505 | - |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 498.90 per share. | 23 Sep 2026 | 90 | 324,683 (0%) | 0% | 498.9 | 44,901 | - |
| Prosperity Bancshares Inc | Mr. Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 67.69 per share. | 23 Sep 2026 | 89 | 84,104 (0%) | 0% | 67.7 | 6,024 | - |
| Kohl`s Corp | Mr. H. Charles Floyd | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 88 | 64,591 (0%) | 0% | - | - | |
| Kohl`s Corp | Ms. Robbin Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 88 | 52,763 (0%) | 0% | - | - | |
| Civista Bancshares Inc | Mr. Charles A. Parcher | President | Purchase of securities on an exchange or from another person at price $ 26.75 per share. | 23 Sep 2026 | 85 | 3,150 (0%) | 0% | 26.8 | 2,274 | - |
| Prosperity Bancshares Inc | Mr. Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 68.56 per share. | 23 Sep 2026 | 82 | 38,700 (0%) | 0% | 68.6 | 5,622 | - |
| Timberland Bancorp Inc | Mr. Michael John Stoney | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.82 per share. | 23 Sep 2026 | 80 | 8,960 (0%) | 0% | 44.8 | 3,586 | - |
| Timberland Bancorp Inc | Mr. Michael John Stoney | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.11 per share. | 23 Sep 2026 | 75 | 8,885 (0%) | 0% | 45.1 | 3,383 | - |
| Timberland Bancorp Inc | Mr. Matthew Douglas Seath | Chief Risk Officer/EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.83 per share. | 23 Sep 2026 | 75 | 3,080 (0%) | 0% | 44.8 | 3,362 | - |
| Timberland Bancorp Inc | Ms. Breanne D. Antich | Chief Technology Officer/EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.11 per share. | 23 Sep 2026 | 66 | 3,727 (0%) | 0% | 45.1 | 2,977 | - |
| Mosaic | Ms. Sonya C. Little | Director | Grant, award, or other acquisition of securities at price $ 24.72 per share. | 23 Sep 2026 | 65 | 7,351 (0%) | 0% | 24.7 | 1,607 | - |
| Timberland Bancorp Inc | Mr. Matthew Douglas Seath | Chief Risk Officer/EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.10 per share. | 23 Sep 2026 | 60 | 3,020 (0%) | 0% | 45.1 | 2,706 | - |
| Kohl`s Corp | Mr. Yael Cosset | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 58 | 70,876 (0%) | 0% | - | - | |
| Timberland Bancorp Inc | Ms. Parul Bhandari | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.10 per share. | 23 Sep 2026 | 58 | 1,836 (0%) | 0% | 45.1 | 2,616 | - |
| Kohl`s Corp | Mr. Niren Chaudhary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2026 | 55 | 7,603 (0%) | 0% | - | - | |
| Timberland Bancorp Inc | Ms. Parul Bhandari | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.82 per share. | 23 Sep 2026 | 51 | 1,894 (0%) | 0% | 44.8 | 2,286 | - |
| Rapport Therapeutics Inc | Mr. Abraham N. Ceesay, M.B.A. | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.05 per share. | 23 Sep 2026 | 43 | 456,767 | - | 41.0 | 1,765 | - |
| Unilever PLC (ADR) | Mr. Srinivas Phatak | Executive Director,Chief Financial Officer | 23 Sep 2026 | 34 | 58,190 (0%) | 0% | 54.8 | 1,864 | - | |
| Prosperity Bancshares Inc | Mr. Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 67.67 per share. | 23 Sep 2026 | 18 | 38,782 (0%) | 0% | 67.7 | 1,218 | - |
| RGC Resources Inc | Mr. John B. Williamson, III | Director | Purchase of securities on an exchange or from another person at price $ 20.67 per share. | 23 Sep 2026 | 3 | 182,634 (2%) | 0% | 20.7 | 62 | - |
| Precigen Inc | Mr. Harry Thomasian, Jr | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 23 Sep 2026 | 2 | 311,913 (0%) | 0% | 1 | 2 | - |
| Precigen Inc | Mr. Harry Thomasian, Jr | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 23 Sep 2026 | 1 | 311,914 (0%) | 0% | 1 | 1 | - |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.